Vaxart(VXRT) - 2024 Q3 - Quarterly Results

Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results Exhibit 99.1 Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and clinical milestones Conference call today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., November 13, 2024 — Vaxart, Inc. (Nasdaq: VXRT) today announced its business update and financial results for the third quarter of 2024. " ...